University of Maryland, Baltimore
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Maryland, Baltimore sits in the top decile of US sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count).
University of Maryland, Baltimore: 560 sponsored US clinical trials, 103 recruiting.
University of Maryland, Baltimore sponsors 560 registered US clinical trials on ClinicalTrials.gov, 103 of them currently recruiting, and 332 completed. 77 of these trials are in Phase 3-4 (later-stage) and 161 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 14 trials.
Top-decile sponsor footprint
University of Maryland, Baltimore ranks in the top decile of sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
332 of 410 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
560 total, page 9 of 12
Exercise Trial in Chronic Kidney Disease
NCT01462097
Gingival Augmentation Around Implants During Maintenance
NCT02904551
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
NCT01452152
Intervention to Enhance Lateral Balance Function and Prevent Falls in Aging
NCT01370174
MobileMedMinder: A Networked Aide for Medication Compliances
NCT01597583
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
NCT01431157
MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)
NCT01768442
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
NCT01413529
Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria
NCT01481935
Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
NCT02619552
Duloxetine for the Treatment of Chronic Pelvic Pain
NCT01451606
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
NCT01531530
Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin
NCT01558570
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
NCT01433055
Development of a Rehabilitation Strengthening and Mobility Program for Ventilator Dependent Older Patients
NCT03195127
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
NCT01541644
RCT Determining Best Treatment for Geriatric Acetabular Fractures
NCT03419182
Safe Kidney Care Cohort Study
NCT01407367
Comparison of Lokomat and Aquatic Exercise for Individuals With Chronic Incomplete Spinal Cord Injury
NCT01407354
Smart Glucose Meter Project
NCT01341587
Cimetidine Biowaivers
NCT01256879
Telehome Monitoring for Chronic Disease Management
NCT02035566
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
NCT01338298
Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil
NCT01276184
Brain Circuits in Schizophrenia and Smoking
NCT01425684
Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention
NCT02055417
Benefits of Universal Glove and Gowning
NCT01318213
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671
Nicotinic Modulation of the Default Network
NCT01223404
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
NCT00607646
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
NCT01234532
Face Transplantation
NCT01140087
R5 Integrase Study in HIV-1 Naive Patients
NCT01204905
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
NCT01246947
Salsalate for Insulin Resistance in Schizophrenia
NCT01182727
Clopidogrel Pharmacogenetics (PGX) Bench to Bedside
NCT01341600
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
NCT01108068
Long-term Follow-up of Spare the Nephron (STN) Patients
NCT01126333
Effects of Galantamine on Cognition
NCT01100775
Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection
NCT01129453
Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
NCT01110226
Chitosan Chewing Gum Study in Dialysis Patients
NCT01770470
Imaging of Traumatic Brain Injury
NCT01196299
Imaging With a Radio Tracer to Guide VT Ablations
NCT01250912
GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
NCT01118975
Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia
NCT01012167
Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
NCT01100762
Telephone Based Cognitive Behavioral Therapy for HIV Related Depression
NCT01055158
Oxytocin and Social Cognition in Schizophrenia
NCT00884897
Safety Study of Seasonal Influenza Vaccine by Jet Injection
NCT00987350
What is open in the University of Maryland, Baltimore pipeline
103 recruiting of 560 indexed (18% open); 332 completed (59%).
Phase mix: 77 late (III/IV) vs 161 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Maryland, Baltimore: open-pipeline peers nationwide
Peers matched on 560 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of Maryland, Baltimore sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 560 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- Henry Ford Health System · 18% recruiting · 234 trials
- New York Institute of Technology · 18% recruiting · 49 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this University of Maryland, Baltimore page
560 registered trials is a research-attention snapshot, not an endorsement of University of Maryland, Baltimore or any single study.
- 103 of University of Maryland, Baltimore's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition University of Maryland, Baltimore studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Maryland, Baltimore pipeline card: 560 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.